ArticleScientific reports2025
Socioeconomic position and cancer stage at diagnosis in a fragmented Latin American health system.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Early cancer diagnosis is crucial to improving disease prognosis. Although several studies have investigated the relationship between socioeconomic position (SEP) and stage at diagnosis, there is limited evidence from contexts with highly fragmented health systems and pronounced socioeconomic inequalities. This study analyzed the association between SEP and stage of cancer diagnosis. Data were obtained from the EquityCancer-LA baseline study. The sample included patients aged 18 or older with a confirmed cancer diagnosis within the 12 months prior to participation. Cancer stage was determined by the oncology committees of participating healthcare centers and logistic regression models were used to assess the association between SEP and cancer stage at diagnosis. A total of 343 individuals participated in the study, 39.1% of whom were diagnosed at a late stage. Two SEP indicators were associated with this outcome. After adjusting for covariates, participants without formal income had higher odds of late-stage diagnosis (OR = 2.14; 95% CI 1.02-4.53), and those who were non-head of household (OR = 1.83; 95% CI 1.11-3.02). When adjusting for all SEP variables, only non-head of household condition remained significantly associated (OR = 1.77; 95% CI 1.07-2.96). These results show that disadvantaged SEP was associated with higher odds of late-stage cancer diagnosis. The findings suggest the need for strategies that promote early diagnosis and address the socioeconomic inequities identified in this study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.